245 related articles for article (PubMed ID: 28774279)
1. Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease.
Li J; Ning NY; Rao QX; Chen R; Wang LJ; Lin ZQ
BMC Cancer; 2017 Aug; 17(1):517. PubMed ID: 28774279
[TBL] [Abstract][Full Text] [Related]
2. Impact of Poor Preoperative Glycemic Control on Outcomes among Patients with Cervical Cancer Undergoing a Radical Hysterectomy.
Liang SH; Shen YC; Wu JY; Wang LJ; Wu MF; Li J
Oncol Res Treat; 2020; 43(1-2):10-18. PubMed ID: 31747660
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer.
Li J; Wu MF; Lu HW; Chen Q; Lin ZQ; Wang LJ
Cancer Med; 2016 Aug; 5(8):1863-72. PubMed ID: 27350066
[TBL] [Abstract][Full Text] [Related]
4. The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy.
Wu MF; Guan MM; Liu CH; Wu JY; Rao QX; Li J
Cancer Med; 2019 Sep; 8(11):5068-5078. PubMed ID: 31310455
[TBL] [Abstract][Full Text] [Related]
5. Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer.
Li J; Wu MF; Lu HW; Zhang BZ; Wang LJ; Lin ZQ
PLoS One; 2016; 11(11):e0166612. PubMed ID: 27851819
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
7. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Radical Surgery Alone in Locally Advanced Cervical Cancer Patients.
Gong L; Zhang JW; Yin RT; Wang P; Liu H; Zheng Y; Lou JY; Peng ZL
Int J Gynecol Cancer; 2016 May; 26(4):722-8. PubMed ID: 26905330
[TBL] [Abstract][Full Text] [Related]
9. Are biomarkers expression and clinical-pathological factors predictive markers of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer?
Ditto A; Longo M; Chiarello G; Mariani L; Paolini B; Leone Roberti Maggiore U; Martinelli F; Bogani G; Raspagliesi F
Eur J Surg Oncol; 2024 Jun; 50(6):108311. PubMed ID: 38554552
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study.
Gadducci A; Cosio S; Zola P; Tisi G; Ferrero A; Piovano E; Cristofani R; Greco C; Sartori E
Int J Gynecol Cancer; 2010 Nov; 20(8):1399-404. PubMed ID: 21051984
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival.
Buda A; Lissoni AA; Floriani I; Biagioli E; Gerardi C; Bonazzi C; Chiari S; Locatelli L; Dell'Anna T; Signorelli M; Mangioni C; Milani R
Int J Gynecol Cancer; 2015 Oct; 25(8):1468-75. PubMed ID: 26222484
[TBL] [Abstract][Full Text] [Related]
12. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
[TBL] [Abstract][Full Text] [Related]
13. How often parametrial involvement leads to post-operative adjuvant treatment in locally advanced cervical cancer after neoadjuvant chemotherapy and type C radical hysterectomy?
Martinelli F; Bogani G; Ditto A; Carcangiu M; Papadia A; Lecce F; Chiappa V; Lorusso D; Raspagliesi F
Eur J Surg Oncol; 2015 Aug; 41(8):1089-96. PubMed ID: 25890492
[TBL] [Abstract][Full Text] [Related]
14. Robotic Surgery in Patients With Locally Advanced Cervical Cancer After Neoadjuvant Chemotherapy: Survival Outcomes.
Siesto G; Romano F; Accardi A; Bulletti C; Iedà NP; Vitobello D
Int J Gynecol Cancer; 2016 Mar; 26(3):521-7. PubMed ID: 26825842
[TBL] [Abstract][Full Text] [Related]
15. Decreasing expression of HIF-1α, VEGF-A, and Ki67 with efficacy of neoadjuvant therapy in locally advanced cervical cancer.
Zhao K; Hu M; Yang R; Liu J; Zeng P; Zhao T
Medicine (Baltimore); 2023 May; 102(20):e33820. PubMed ID: 37335690
[TBL] [Abstract][Full Text] [Related]
16. Optimal pathological response indicated better long-term outcome among patients with stage IB2 to IIB cervical cancer submitted to neoadjuvant chemotherapy.
Huang K; Sun H; Chen Z; Li X; Wang S; Zhao X; Tang F; Jia Y; Hu T; Du X; Wang H; Lu Z; Huang J; Gui J; Wang X; Zhou S; Wang L; Zhang J; Guo L; Yang R; Shen J; Zhang Q; Li S; Wang S
Sci Rep; 2016 Jun; 6():28278. PubMed ID: 27325186
[TBL] [Abstract][Full Text] [Related]
17. 15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer.
Hu M; Li K; Maskey N; Xu Z; Peng C; Tian S; Li Y; Yang G
Int J Clin Exp Pathol; 2015; 8(6):6910-8. PubMed ID: 26261578
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer.
Huang Y; Chen L; Cai J; Yang L; Sun S; Zhao J; Xiong Z; Wang Z
World J Surg Oncol; 2022 Aug; 20(1):264. PubMed ID: 35996118
[TBL] [Abstract][Full Text] [Related]
19. High hemoglobin A
Arya S; Binney ZO; Khakharia A; Long CA; Brewster LP; Wilson PW; Jordan WD; Duwayri Y
J Vasc Surg; 2018 Jan; 67(1):217-228.e1. PubMed ID: 28844470
[TBL] [Abstract][Full Text] [Related]
20. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
Mathiesen RR; Borgen E; Renolen A; Løkkevik E; Nesland JM; Anker G; Ostenstad B; Lundgren S; Risberg T; Mjaaland I; Kvalheim G; Lønning PE; Naume B
Breast Cancer Res; 2012 Aug; 14(4):R117. PubMed ID: 22889108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
